Form 8-K - Current report:
SEC Accession No. 0001558370-20-006989
Filing Date
2020-05-27
Accepted
2020-05-27 07:03:26
Documents
43
Period of Report
2020-05-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20200527x8k.htm 8-K 30125
2 EX-99.1 tmb-20200527xex99d1.htm EX-99.1 68253
3 GRAPHIC tmb-20200527xex99d1g001.jpg GRAPHIC 272905
4 GRAPHIC tmb-20200527xex99d1g002.jpg GRAPHIC 503429
5 GRAPHIC tmb-20200527xex99d1g003.jpg GRAPHIC 292606
6 GRAPHIC tmb-20200527xex99d1g004.jpg GRAPHIC 333171
7 GRAPHIC tmb-20200527xex99d1g005.jpg GRAPHIC 204042
8 GRAPHIC tmb-20200527xex99d1g006.jpg GRAPHIC 318899
9 GRAPHIC tmb-20200527xex99d1g007.jpg GRAPHIC 245079
10 GRAPHIC tmb-20200527xex99d1g008.jpg GRAPHIC 282769
11 GRAPHIC tmb-20200527xex99d1g009.jpg GRAPHIC 286360
12 GRAPHIC tmb-20200527xex99d1g010.jpg GRAPHIC 131747
13 GRAPHIC tmb-20200527xex99d1g011.jpg GRAPHIC 260199
14 GRAPHIC tmb-20200527xex99d1g012.jpg GRAPHIC 343547
15 GRAPHIC tmb-20200527xex99d1g013.jpg GRAPHIC 297286
16 GRAPHIC tmb-20200527xex99d1g014.jpg GRAPHIC 299898
17 GRAPHIC tmb-20200527xex99d1g015.jpg GRAPHIC 362144
18 GRAPHIC tmb-20200527xex99d1g016.jpg GRAPHIC 337622
19 GRAPHIC tmb-20200527xex99d1g017.jpg GRAPHIC 306672
20 GRAPHIC tmb-20200527xex99d1g018.jpg GRAPHIC 302566
21 GRAPHIC tmb-20200527xex99d1g019.jpg GRAPHIC 339070
22 GRAPHIC tmb-20200527xex99d1g020.jpg GRAPHIC 287289
23 GRAPHIC tmb-20200527xex99d1g021.jpg GRAPHIC 283160
24 GRAPHIC tmb-20200527xex99d1g022.jpg GRAPHIC 223987
25 GRAPHIC tmb-20200527xex99d1g023.jpg GRAPHIC 262286
26 GRAPHIC tmb-20200527xex99d1g024.jpg GRAPHIC 323376
27 GRAPHIC tmb-20200527xex99d1g025.jpg GRAPHIC 164460
28 GRAPHIC tmb-20200527xex99d1g026.jpg GRAPHIC 238773
29 GRAPHIC tmb-20200527xex99d1g027.jpg GRAPHIC 220138
30 GRAPHIC tmb-20200527xex99d1g028.jpg GRAPHIC 213551
31 GRAPHIC tmb-20200527xex99d1g029.jpg GRAPHIC 190380
32 GRAPHIC tmb-20200527xex99d1g030.jpg GRAPHIC 203735
33 GRAPHIC tmb-20200527xex99d1g031.jpg GRAPHIC 141357
34 GRAPHIC tmb-20200527xex99d1g032.jpg GRAPHIC 288611
35 GRAPHIC tmb-20200527xex99d1g033.jpg GRAPHIC 280939
36 GRAPHIC tmb-20200527xex99d1g034.jpg GRAPHIC 191494
37 GRAPHIC tmb-20200527xex99d1g035.jpg GRAPHIC 137774
38 GRAPHIC tmb-20200527xex99d1g036.jpg GRAPHIC 267623
39 GRAPHIC tmb-20200527xex99d1g037.jpg GRAPHIC 238592
40 GRAPHIC tmb-20200527xex99d1g038.jpg GRAPHIC 271663
41 GRAPHIC tmb-20200527xex99d1g039.jpg GRAPHIC 210662
42 GRAPHIC tmb-20200527xex99d1g040.jpg GRAPHIC 163939
43 GRAPHIC tmb-20200527xex99d1g041.jpg GRAPHIC 262711
  Complete submission text file 0001558370-20-006989.txt   14962290
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 20912720
SIC: 2834 Pharmaceutical Preparations